¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength Arthritis Foundation Safety Coated Aspirin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® aspirin ÇÑ±Û ¾Æ½ºÇǸ°
¼³¸í   
  ½ºÅ×·ÎÀ̵尡 ¾Æ´Ñ Ç׿°Á¦ÀÇ ´ëÇ¥ÀûÀΠ¾à¹°ÀÌ´Ù. Ç׿°Áõ, ÁøÅë, ÇØ¿­ÀÇ 3°¡Áö ±â´ÉÀ» °¡Áø´Ù. ¾à¹°ÀÇ ±â´ÉÀº ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandin)ÀÇ Çü¼ºÀ» ¾ïÁ¦Çϴ °Í¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. ¿°ÁõÀ̶õ ¸ö¼Ó¿¡ µé¾î¿Â À̹°ÁúÀ» Ã³¸®Çϴ °úÁ¤À¸·Î ¿©±â¿¡´Â ¿©·¯ °¡Áö ¼¼Æ÷°¡ °ü¿©ÇÑ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµò´Â ¿°ÁõÀÇ °úÁ¤¿¡¼­ ¿©·¯ ¼¼Æ÷¸¦ ¸ðÀ¸´Â ±â´ÉÀ» Çϴ ¹°ÁúÀÌ´Ù. Áï ÇÁ·Î½ºÅ¸±Û¶õµòÀÇ Çü¼ºÀ» ¸·À¸¸é ¿°Áõ¿¡ °ü¿©Çϴ ¼¼Æ÷ÀÇ ÁýÇÕÀÌ ÀÌ·ç¾îÁöÁö ¾Ê¾Æ¼­ ¿°ÁõÀÌ ÀϾÁö ¾Ê´Â´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ °ü¿©ÇÑ´Ù. Ãʱ⿡ Ç÷°üÀÌ ÅÍÁ® Çǰ¡ ³¯ ¶§¿¡ À̰ÍÀ» ¸·´Â °ÍÀº Ç÷¼ÒÆÇÀÌ´Ù. Áï Ç÷¼ÒÆÇÀÌ ¸ð¿© Ç÷°üÀÇ ¼Õ»óµÈ ºÎÀ§¸¦ Æ²¾î¸·°Ô µÈ´Ù. ¿ª½Ã ÀÌ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ Ç÷¼ÒÆÇÀ» ±× ºÎºÐ¿¡ ¸ðÀ̰ԠÇϴ ¿ªÇÒÀ» ¼öÇàÇϹǷΠ¾Æ½ºÇǸ°À» ¸ÔÀ¸¸é ÁöÇ÷ÀÌ Àß µÇÁö ¾Ê´Â´Ù. ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­Àå¾Ö, ÁöÇ÷ÀÇ Àå¾Ö, ¾ÆÁÖ µå¹°Áö¸¸ ¼Ò¾Æ¿¡¼­ Ä¡¸íÀûÀΠ¶óÀÌÁõÈıºÀÌ »ý±æ ¼ö°¡ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ¿¡¼± Á¶½ÉÇØ¼­ »ç¿ëÀ» ÇؾߠÇÑ´Ù. ¾Æ¼¼»ì¸®½Ç»ê ÂüÁ¶.
¿µ¹® arthritis ÇÑ±Û °üÀý¿°
¼³¸í   
  °üÀý¿¡ ÀϾ ¿°Áõ. ¿øÀο¡ µû¶ó È­³ó¼º-°áÇÙ¼º-¸Åµ¶¼º µî °¨¿°¼º°ú ·ù¸¶Æ¼½º¿¡ ÀÇÇÑ °Í, ¿Ü»óÀ¸·Î ÀÎÇÑ °Í µîÀ¸·Î ³ª´«´Ù. ÀÓ»ó»óÀ¸·Î´Â ±Þ¼º°ú ¸¸¼ºÀ¸·Î ³ª´¶´Ù. 1. ±Þ¼º. ¨ç Àå¾×°üÀý¿°: º¸Å렿ܻ󿡠ÀÇÇØ ÀϾ¸ç ¿øÀκҸíÀÇ °Íµµ ÀÖÀ¸³ª ´ë°³ ÇϳªÀÇ °üÀý¿¡¸¸ ¹ß»ýÇÑ´Ù. ¨è Àå¾×¼¶À¯¼Ò°üÀý¿°: ±Þ¼º°üÀý ·ù¸¶Æ¼½º ¶§¿¡ ÀϾ¸ç, °üÀý°­³»¿¡ È¥Å¹ÇÑ »ïÃâ¾×ÀÌ °íÀδÙ. ¼¶À¯¼ÒÀÇ °ÅÁþ¸·ÀÌ »ý°Ü ¿°ÁõÀÌ °¡¶ó¾É¾Æµµ ½ÉÇÑ ¿îµ¿Àå¾Ö¸¦ ³²±ä´Ù. ¨é È­³ó°üÀý¿°: °üÀýÀÇ °³¹æÃ¢ ¶Ç´Â ÀÓÁú-¼ºÈ«¿­-ÆÐÇ÷Áõ °°Àº Àü¿°º´¿¡ ´Ù¹ß¼ºÀ» º¸ÀδÙ. »ýÈÄ 1~2°³¿ùÀÇ À¯¾Æ´Â »À°¡ ½ÉÇϰԠ»óÇÏ¿© Ä¡·áÇÒ ¼ö ¾ø´Â Å»±¸¸¦ ÀÏÀ¸Å²´Ù. ¼ºÀο¡¼­´Â »À¸·°ñ¼ö¿°¿¡ °É·Á È­³óºÎ°¡ ÅÍÁ® °í¸§ÀÌ °üÀý·Î µé¾î°¡´Â °ÍÀÌ ¸¹À¸¸ç, À̸¦ 2Â÷È­³ó°üÀý¿°À̶ó°í ÇÑ´Ù. 2. ¸¸¼º. ¨ç Æ¯¼ö¿°Áõ: °áÇÙ¼º-¸Åµ¶¼º È¤Àº Áß³â ÀÌÈÄÀÇ ³²ÀÚ¿¡ ¸¹Àº ¿ä»êÀÇ ´ë»ç Àå¾Ö·Î ÀÎÇÑ Åëdz¼º °üÀý¿°ÀÌ ÀÖ´Ù. ¨è ´Ù¹ß°üÀý¿°: ¸¸¼º°üÀý ·ù¸¶Æ¼½º¿¡ ÀÇÇÑ °ÍÀÌ ¸¹À¸¸ç ±Þ¼ºÀå¾×°üÀý¿°¿¡¼­ ÀÌÇàÇÑ °Í°ú °áÇÙ-¸Åµ¶-ÀÓÁúÀÇ °æ°ú Áß¿¡ º¼ ¼ö Àִ ´Ù¹ß¼º ¹× ÆÐÇ÷ÁõÀÇ Çϳªµµ ÀÖ°í, ¿©±â¿¡´Â ½ºÆ¿º´À̶ó´Â °üÀý¿°µµ Æ÷ÇԵȴÙ. ¨é º¯Çü°ñ°üÀý¿°: »À³ª °üÀýÀÇ ³ëÈ­ ¶Ç´Â ¿Ü»óÀÌ ¿øÀÎÀÌ´Ù. ¨ê Ç÷¿ìº´°ýÀý¿°: Ç÷¿ìº´À» ¾ÎÀ» ¶§ °üÀý ³»ÀÇ ÃâÇ÷¿¡ ÀÇÇÑ °ÍÀÌ´Ù.
¿µ¹® rheumatoid arthritis ÇÑ±Û ·ù¸¶Æ¼½º°üÀý¿°
¼³¸í   
  ¸¸¼ºÀÇ °üÀýº´À¸·Î º¸Åë ¿©·¯ °üÀýÀ» Ä§¹üÇϸç, À±È°¸·(°üÀýÀ» µÑ·¯½Î°í ÀÖÀ¸¸ç, °üÀýÀÇ ¿òÁ÷ÀÓÀ» ¸¶Âû¾øÀÌ ¿øÈ°ÇϰԠ¼öÇàµÇµµ·Ï ÇÔ), °üÀý±¸Á¶ÀÇ ¿°Áõ¼º º¯È­¿Í »ÀÀÇ À§Ãà°ú ¼Ò¸ð°¡ µÎµå·¯Áø´Ù. ¸»±â¿¡´Â º¯Çü°ú °­Á÷ÀÌ ÀϾ¸ç ¿øÀÎÀº ºÒ¸íÀ̳ª ÀÚ°¡¸é¿ª¼º ¶Ç´Â ¹ÙÀÌ·¯½ºÀÇ °¨¿°¿¡ ÀÇÇÑ °ÍÀ¸·Î »ý°¢µÈ´Ù. Ä¡·á´Â °è¿­ÀÇ ¼Ò¿°ÁøÅëÁ¦°¡ »ç¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • aspirin
    ¾Æ½ºÇǸ°
  • denture foundation area
    ÀÇÄ¡±âÀú¸é
  • foundation
    ±âÃÊ
  • coated
    ÇǸ·-
  • coated tongue
    À̳¢Çô, ż³
  • enteric-coated tablet
    Àå¿ëÇØ¾Ë¾à
  • biological safety cabinet
    »ý¹°ÇÐÀû¾ÈÀü½ÇÇè´ë
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety
    1. ¾ÈÀü 2. ¾ÈÀü¼º
  • safety control
    ¾ÈÀü°ü¸®
  • safety factor
    ¾ÈÀü°è¼ö
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • foundation
    ±âÃÊ
  • arthritis
    °üÀý¿°
  • arthrocaries arthritis
    °áÇÙ°üÀý¿°
  • erosive arthritis
    ±îÁü°üÀý¿°, ¹Ì¶õ°üÀý¿°
  • safety control
    ¾ÈÀü°ü¸®
  • safety
    ¾ÈÀü, ¾ÈÀüµµ
  • safety standard
    ¾ÈÀü±âÁØ
  • maximum dose
    ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
  • maximum
    ÃÖ´ë
  • scatter-maximum ratio
    ÃÖ´ë»ê¶õºñ
  • strength
    Èû, ¼¼±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • physical strength
    ü·Â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • denture foundation area
    ÀÇÄ¡±âÀú¸é
  • foundation
    ±âÃÊ
  • coated
    ÇǸ·-
  • coated erythrocyte
    ÇǸ·ÀûÇ÷±¸
  • coated tongue
    À̳¢Çô, ż³
  • enteric-coated tablet
    âÀÚµµÂø¾Ë¾à
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·ÀûÇ÷±¸
  • biological safety cabinet
    »ý¹°ÇÐÀû¾ÈÀü½ÇÇè´ë
  • safety cabinet
    ¹«±Õ½ÇÇè´ë
  • safety control
    ¾ÈÀü°ü¸®
  • safety factor
    ¾ÈÀü°è¼ö
  • material safety data sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • MR safety
    ÀÚ±â°ø¸í¾ÈÀüµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·<--¿Ü¸·>ÀûÇ÷±¸
  • immunoglobulin-coated erythrocyte
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂøÀûÇ÷±¸
  • fracture strength
    ÆÄÀý °­µµ.
  • fracture strength
    ÆÄÀý°­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • MR safety
    ÀÚ±â°ø¸í ¾ÈÀüµµ
  • MSDS => Material Safety Data Sheet
    ¹°Áú¾ÈÀüÀÚ·á¿ëÁö
  • pop valve =safety v.
    ¾ÈÀüÆÇ(äÌîï÷û).
  • protective spectacles =safety goggles
    ¹æÈ£¾È°æ(ËÑÌ´ËâË­).
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • MAC=> maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ.
  • MBC=£¾maximum breathing capacity
    ÃÖ´ëÈ£Èí(¿ë)·®, ÃÖ´ëȯ±â·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum safety pressure
    ÃÖ´ë¾ÈÀü¾Ð.
  • denture foundation area
    ÀÇÄ¡±âÀú¸é.
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • aspirin
    ¾Æ½ºÇǸ°.
  • aspirin
    ¾Æ½ºÇǸ°
  • aspirin
    ¾Æ½ºÇǸ°
  • clathrin-coated pit
    Ŭ¶ó½º¸° ÇǸ· Ȩ
  • coated erythrocyte
    ÇǸ·ÀûÇ÷±¸
  • enteric (coated) tablet =ECT
    Àå¿ëÇǺ¹Á¤(íóéÁïü).
  • filmy tongue =coated t.
    ż³
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·<--¿Ü¸·>ÀûÇ÷±¸
  • immunoglobulin-coated erythrocyte
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂøÀûÇ÷±¸
  • tongue, filmy [=coated t.]
    ż³
  • biological safety cabinet
    »ý¹°ÇÐÀû ¾ÈÀüÇÔ(ùÞ)
  • margin of safety
    ¾ÈÀü¿ª.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • coated pit
    ´þÈù Ȩ
  • coated vesicle
    ´þÈù ¼ÒÆ÷(á³øÐ)
  • bond strength
    °áÇÕ·Â(Ì¿ùêÕô)
  • dipole strength
    ½Ö±ØÀÚ(äªÐ¿í­) ¼¼±â
  • eluent strength
    ¿ë¸®(éÁ×î) ¼¼±â
  • ionic strength
    À̿ °­µµ(Ë­Óø)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • maximum permissible body burden
    ÃÖ´ëü³»Çã¿ëºÎ´ã(õÌÓÞô÷Ò®úÉé»Ý¶Ó½)
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØÓø)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
  • maximum velocity
    ÃÖ´ë¼Óµµ(õÌÓÞáÜÓø)
  • promoter strength
    ÇÁ·Î¸ðÅÍ °­µµ(Ë­Óø)
  • rotational strength
    ȸÀü(üÞï®) ¼¼±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • aspirin
    ¾Æ½ºÇǸ°
  • MR safety
    ÀÚ±â°ø¸í¾ÈÀüµµ
  • safety
    ¾ÈÀü(¼º)
  • safety margin
    ¾ÈÀü¿ª, ¾ÈÀüÇѰè
  • maximum
    ÃÖ´ë, ÃÖ°í
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum permissible dose [=MPD]
    ÃÖ´ëÇã¿ë(¼±)·®
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
  • arthritis
    °üÀý¿°
  • arthritis nodosa
    °áÀý¼º°üÀý¿°
  • degenerative arthritis
    ÅðÇ༺°üÀý¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
CCT carotid compression tomography; central conduction time; cerebrocranial trauma; chocolate-coated tab...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ASA Aspirin
AIA Aspirin induced Asthma
ASP aspirin
CCF Cleveland Clinic Foundation
JDF Juvenile Diabetes Foundation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum foundation plane
    ÀÇÄ¡»ó Æò±Õ Àú¸é
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • aspirin
    ¾Æ½ºÇǸ°
    Ç׿°Áõ, ÁøÅë ¹× ÇØ¿­Á¦. PGs »ýÇÕ¼º °úÁ¤¿¡¼­ syclooxygenase¸¦ ¾ïÁ¦ÇÏ¿© ¿°Áõ ¹ÝÀÀ¿¡¼­ ¾ß±âµÇ´Â ¿©·¯ °¡Áö ÀÓ»ó Áõ»óÀ» ¼Ò½ÇÄÉ ÇÑ´Ù. ¶ÇÇÑ Ç÷¼ÒÆÇ ÀÀÁýÀ» ¾ïÁ¦ÇÏ´Â ÀÛ¿ëÀÌ ÀÖÀ¸¸ç ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­¼º ±Ë¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.
  • denture foundation area
    ÀÇÄ¡ ±âÀú¸é
    ÀÇÄ¡ÀÇ ÁöÁö¿¡ ±â¿©ÇÏ´Â ±¸°­³» Á¶Á÷ÀÌ´Ù.
  • foundation
    ±âÃÊ
    ¹«¾ùÀΰ¡ ±× À§¿¡ ¼¼¿öÁö´Â ±¸Á¶ ¶Ç´Â ±âÀú.
  • coated
    ÇǸ·ÀÌ Çü¼ºµÈ, µ¤Èù
  • coated tongue
    ¼³ÅÂ, ż³
    ¹Ú¸®µÈ »óÇÇ ¼¼Æ÷, ¸ð»ó À¯µÎ, ¼¼±Õ, À½½Ä¹° ÀÜ»ç·Î ±¸¼ºµÈ ÇǺ¹À¸·Î½á ¼Ò°ßÀÌ ¸Å¿ì ´Ù¾çÇÏ´Ù. ¸ð¼³ÀÇ Áß°£ ´Ü°èÀÌ´Ù.
  • enteric-coated
    Àå¿ëÁ¦ÇÇÀÇ
    Á¤Á¦ ¶Ç´Â ĸ½¶Á¦°¡ Àå¿¡ µµ´ÞÇϱâ ÀÌÀü¿¡´Â ±×ÀÇ ³»¿ëÀÌ ¹æÃâÀ̳ª Èí¼öµÇÁö ¸øÇÏ°Ô Çϱâ À§ÇÏ¿© °ÑÀ» ½Ñ Ư¼öÇÑ ¿ÜÇǸ¦ ÀÏÄ´ ¿ë¾î.
  • yellowish-coated
    Ȳ»öÀ¸·Î µ¤Çô ÀÖ´Â
  • biological safety cabinet
    »ý¹°ÇÐÀû ¾ÈÀüÇÔ
  • hospital laser safety officer
    º´¿øÀÇ ·¹ÀÌÀú ¾ÈÀü °ü¸®ÀÚ
    ÀÇÇÐ ºÐ¾ß¿¡¼­ ·¹ÀÌÀúÀÇ ¾ÈÀüÇÑ Á¶ÀÛÀ» ¼öÇàÇϴµ¥ ÇÊ¿äÇÑ ¸ðµç ¹æ¹ýÀ» °ü¸® Á¶ÀýÇÏ´Â »ç¶÷.
  • laser safety officier
    ·¹ÀÌÀú ¾ÈÀü°ü¸®ÀÚ
    Ư¼öÇÑ °Ç°­ °ü¸® Àåºñ¸¦ ´Ù·ç´Â ¸ðµç »ç¶÷¿¡ ´ëÇÑ ±³À°°ú ÈÆ·ÃÀ» ´Ù·ç°í ÀÖ´Â ·¹ÀÌÀú ¾ÈÀü ÇÁ·Î±×·¥À» °ü¸®ÇÏ°í ¼öÇàÇÏ´Â »ç¶÷.
  • margin of safety
    ¾ÈÀü ¿ª
  • MR safety
    Àڱ⠰ø¸í ¾ÈÀüµµ
  • safety
    ¾ÈÀü, ¾ÈÁ¤¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aluminum aspirin An analgesic and antipyretic.
Synonym: aluminum acetylsalicylate.
(05 Mar 2000)
aspirin <drug> Acetyl salicylate. An analgesic, antipyretic and antinflammatory drug. It is a potent cyclooxygenase inhibitor and blocks the formation of prostaglandins from arachidonic acid.
(18 Nov 1997)
mean foundation plane The mean of the various irregularities in form and inclination of the basal seat; the ideal condition for denture stability exists when the mean foundation plane is most nearly at right angles to the direction of force.
(05 Mar 2000)
National Science Foundation <organisation> A nonregulatory U.S. Federal agency which has oversight of biotechnology research activities that the agency funds.
(09 Oct 1997)
denture foundation That portion of the oral structures which is available to support a denture.
See: denture foundation area, denture foundation surface, mean foundation plane.
(05 Mar 2000)
denture foundation area That portion of the basal seat which supports the complete or partial denture base under occlusal load.
Synonym: basal seat, denture-bearing area, denture-supporting area, stress-bearing area, supporting area, tissue-bearing area.
(05 Mar 2000)
denture foundation surface That portion of the surface of a denture which has its contour determined by the impression and bears the greater part of the occlusal load.
Synonym: denture basal surface.
(05 Mar 2000)
foundation A base; a supporting structure.
(05 Mar 2000)
antibody-coated bacteria test, urinary Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.
(12 Dec 1998)
coated pit <biology> First stage in the formation of a coated vesicle.
(18 Nov 1997)
coated pits, cell-membrane Specialised regions of the cell membrane composed of pits coated with a bristle covering made of the protein clathrin. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalised into the cytoplasm to form the coated vesicles.
(12 Dec 1998)
coated tongue A tongue with a whitish layer on its upper surface, composed of epithelial debris, food particles, and bacteria; often an indication of indigestion or of fever.
Synonym: furred tongue.
(05 Mar 2000)
coated vesicle <cell biology> Vesicle formed as an invagination of the plasma membrane (a coated pit) and that is surrounded by a basket of clathrin. Associated with receptor mediated pinocytosis and receptor recycling.
(18 Nov 1997)
coated vesicles Vesicles formed when cell-membrane coated pits (coated pits, cell-membrane) invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of the protein clathrin. Shortly after formation, however, the clathrin coat is removed and the vesicles are referred to as endosomes.
(12 Dec 1998)
tablets, enteric-coated Tablets coated with material that delays release of the medication until after they leave the stomach.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • arthritis
    °üÀý¿°
  • aspirin
    ¾Æ½ºÇǸ°
  • coated
    ±¤À» ³½(¹øÂ½ÀÌ´Â)(Á¾ÀÌ µî);¹æ¼ö°¡°øÇÑ (õ);°Ñ¿¡ ¹Ù¸¥ (ÀÔÈù)
  • coated paper
    ¾ÆÆ®Áö(±¤ÅÃÁö)
  • rheumatoid arthritis
    ·ù¸ÓƼÁò¼º °üÀý¿°
  • maximum
    ÃÖ´ë; ÃÖ°í; ±ØÇÑ
  • strength
    Èû,¼¼·Â,ÀåÁ¡
  • field strength
    ÀåÀÇ ¼¼±â;Àü°è °­µµ
  • impact strength
    (Àç·áÀÇ)Ãæ°Ý °­µµ
  • maximum
    ÃÖ´ëÇѵµ
  • maximum dose
    (¾àÀÇ) ±Ø·®
  • maximum permissible dosage
    (¹æ»ç´É) ÃÖ´ë Çã¿ë Á¶»ç Àû·®
  • maximum thermometer
    ÃÖ°í ¿Âµµ°è
  • radio field intensity (strength)
    ÀüÆÄ °­µµ;ÀüÀÚÀå °­µµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á